ASXL2 mutation is recurrent in non-de novo AML1-ETO-negative acute myeloid leukemia

被引：0
|
作者：
Xiang Zhang
Jie Jin
Wenjuan Yu
机构：
[1] Zhejiang University College of Medicine,Department of Hematology, The First Affiliated Hospital
[2] Zhejiang University,Institute of Hematology
[3] Key Laboratory of Hematologic Malignancies,undefined
[4] Diagnosis and Treatment,undefined
[5] Zhejiang,undefined
来源：
Annals of Hematology | 2019年 / 98卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2621 / 2623
页数：2
相关论文
共 50 条
  • [21] Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia
    Kobayashi, M.
    Chen, S.
    Bai, Y.
    Yao, C.
    Gao, R.
    Sun, X-J
    Mu, C.
    Twiggs, T. A.
    Yu, Z-H
    Boswell, H. S.
    Yoder, M. C.
    Kapur, R.
    Mulloy, J. C.
    Zhang, Z-Y
    Liu, Y.
    LEUKEMIA, 2017, 31 (06) : 1453 - 1457
  • [22] THE AML1 AND ETO GENES IN ACUTE MYELOID-LEUKEMIA WITH A T(821)
    NUCIFORA, G
    ROWLEY, JD
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 353 - 362
  • [23] The coexpression of AML1-ETO9a isoform and AML1-ETO in acute myeloid leukemia M2 subtype and its clinical significance
    Zhang, Hong
    Chen, Zi-xing
    He, Jun
    Miao, Yu-qin
    Cen, Jian-nong
    Qiu, Qiao-chen
    BLOOD, 2007, 110 (11) : 706A - 706A
  • [24] Unusual Presentation of De Novo Acute Myeloid Leukemia (AML-M2): A Case Report
    Saafan, Maged
    Mansour, Reham Osama
    Almahameed, Aws Naseer
    Khalifa, Raghda Ibrahim F.
    El-Ashwah, Shaimaa
    Denewer, May
    Khaled, Nada A.
    Azmy, Emad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S225 - S226
  • [25] DISTINCT CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ADULT PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA WITH ADDITIONAL SEX COMB-LIKE 1 (ASXL1) MUTATION
    Huang, H. H.
    Chou, W. C.
    Hou, H. A.
    Chen, C. Y.
    Tien, H. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 14 - 15
  • [26] A seasonal pattern of presentation in younger patients with de novo acute myeloid leukemia (AML).
    Drapkin, Benjamin Jacob
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Werner, Lillian
    Babirak, Loren
    Attar, Eyal C.
    Ballen, Karen K.
    McAfee, Steven L.
    Amrein, Philip C.
    Chen, Yi-Bin Albert
    Stone, Richard M.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] DE NOVO ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY AND EFFECTIVENESS OF INDUCTION THERAPY (IR)
    Gritsaev, S.
    Martinkevitch, I.
    Kostroma, I.
    Ivanova, M.
    Sergeev, A.
    Martinenko, L.
    Petrova, E.
    Tsibakova, N.
    Zapreeva, I.
    Abdulkadirov, K.
    HAEMATOLOGICA, 2012, 97 : 510 - 510
  • [28] The t(8;21) Fusion Protein AML1/ETO Promotes Susceptibility to Mutation In Acute Myeloid Leukemia.
    Forster, Victoria J.
    Allan, James M.
    Heidenreich, Olaf
    BLOOD, 2010, 116 (21) : 1379 - 1379
  • [29] Molecular pathogenesis of AML (mouse models of acute myeloid leukemia with AML1-ETO fusion proteins)
    Dong-Er Zhang
    International Journal of Hematology, 2002, 76 : 249 - 249
  • [30] The combined expression of AML1-ETO and oncogenic RAS is insufficient to induce acute myeloid leukemia (AML).
    Flotho, C
    Sun, WL
    Shurtleff, S
    Yang, SL
    Downing, JR
    BLOOD, 2004, 104 (11) : 700A - 700A
12345